(AGENPARL) – ven 02 dicembre 2022 2 December 2022 Media and Public Relations News announcement Meeting highlights from the Pharmacovigilance…
Browsing: EMA
(AGENPARL) – mer 23 novembre 2022 22 November 2022 EMA/888780/2022 Media and Public Relations News announcement New Quality Innovation Expert…
(AGENPARL) – lun 21 novembre 2022 21 November 2022 EMA/877400/2022 Media and Public Relations News announcement Best practices to fight…
(AGENPARL) – ven 28 ottobre 2022 28 October 2022 EMA/844036/2022 EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines…
(AGENPARL) – ven 28 ottobre 2022 28 October 2022 EMA/838958/2022 EMA recommends measures to minimise risk of serious side effects…
(AGENPARL) – ven 28 ottobre 2022 28 October 2022 Media and Public Relations News announcement Meeting highlights from the Pharmacovigilance…
(AGENPARL) – ven 14 ottobre 2022 14 October 2022 EMA/CHMP/821618/2022 Media and Public Relations News announcement New vaccine to protect…
(AGENPARL) – ven 14 ottobre 2022 14 October 2022 Media and Public Relations CHMP meeting highlights Meeting highlights from the…
(AGENPARL) – ven 14 ottobre 2022 14 October 2022 EMA/CHMP/821426/2022 Media and Public Relations News announcement First therapy to treat…
(AGENPARL) – ven 07 ottobre 2022 7 October 2022 Media and Public Relations Management Board highlights EMA Management Board: highlights…